维普中文期刊产品整合服务
17篇 您的检索式:作者名="Danzon PM"
    题名 作者 年代 出处 被引量
1International prices and availability of pharmaceuticals in 2005 显示文摘DANZON PM FURUKAWA MF 2008Health Aff (Millwood)2008,27,1:1
2International Prices and Availability of Pharmaceuticals in 2005显示文摘Danzon PM Furukawa MF 2008Health Affair (Millwood)2008,27,1:1
3The Economics of Parallel Trade显示文摘Danzon PM 1998Pharmaco Economics1998,13,3:1
4Differential pricing for pharmaceuticals: reconciling access, R&D and patents显示文摘DANZON PM TOWSE A 2003Int J Health Care Finance Econ2003,3,3:1
5Differential pricing for pharmaceuticals: reconciling access,R&D and patents显示文摘DANZON PM TOWSE A 2003Int J Health Care Finance Econ2003,3,3:1
6Cross-national price differences for pharmaceuticals: how large, and why?显示文摘DANZON PM CHAO LW 2000J Health Econ2000,19,2:1
7The impact of price regu- lation on the launch delay of new drugs-evidence from twenty-five major markets in the 1990s显示文摘DANZON PM WANG YR WANG L 2005Health Econ2005,14,3:1
8Cross-national price differences for phar maceuticals:how large,and why?显示文摘Danzon PM Chao LW 2000Health Economics2000,19,2:1
9At what price?显示文摘Danzon PM 2007Nature2007,,449:1
10Cross-national price differences for pharma ceuticals:how large,and why?显示文摘Danzon PM Chao LW 2000Health Economics2000,19,2:1
11The Swedish Patient Compensation System:Myths and Realities 显示文摘Danzon PM 1994International Review of Law and Econom- ics1994,14,4:1
12International price comparisons for pharmaceuticals显示文摘Danzon PM Kim JD 1998Pharmacoeconomics1998,14,1:1
13Cross-national price differences for pharmaceuticals: how large, and why?显示文摘Danzon PM Chao LW 2000J Health Econ2000,19,2:1
14Prices and availability of ph- armaceuticals: evidence from nine countries显示文摘Danzon PM Furukawa MF 2004Health Aft: Millwood2004,,:1
15Reference pricing of pharmaceuticals for Medicare: evidence from Germany, The Netherlands, and New Zealand 显示文摘Danzon PM Ketcham JD 2004Front Health Policy Res2004,7,:1
16The impact of price regulation on the launch delay of new drugs - evidence from twenty-five major markets in the 1990s 显示文摘Danzon PM Wang YR 2005Health Econ2005,14,3:1
17Reference pricing of pharma- ceuticals for medicare: evidence from Germany, the Netherlands and New Zealand 显示文摘Danzon PM Ketcham JD 2004Health Econ Policy2004,7,1:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费